Babyl & Novo Nordisk partner to provide an innovative approach to diabetes awareness and care in Rwanda
AUSTIN, Texas & KIGALI, Rwanda & LONDON--(BUSINESS WIRE)--Babyl, a subsidiary of Babylon (NYSE: BBLN), and Novo Nordisk announced today that they have entered an innovative partnership to contribute to the expansion of diabetes awareness and care in Rw...